21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 5,7 | 6,7 | 10,4 | 56,4 |
EBITDA | 7,4 | 8,3 | 10,8 | 30 |
Short time liabilities | 20,3 | 18,7 | 19,9 | 6,4 |
Equity capital | 8,1 | 13,4 | 16,8 | 25 |
Operating profit (EBIT) | 6,3 | 7,5 | 10,2 | 36,9 |
Assets | 29,9 | 33,5 | 39 | 16,6 |
Net profit (loss) | 4,6 | 5,3 | 8,2 | 54,1 |
Cash | 5,3 | 3,2 | 1,8 | -44,5 |
Net income from sale | 72,5 | 83,4 | 92,4 | 10,8 |
Liabilities and provisions for liabilities | 21,8 | 20 | 22,2 | 10,9 |
Working assets | 25,1 | 30 | 35,4 | 17,9 |
Depreciation | 1,1 | 0,9 | 0,6 | -30,6 |
% | % | % | p.p. | |
Profitability of capital | 56,8 | 39,6 | 48,9 | 9,3 |
Equity capital to total assets | 27,1 | 40,1 | 43 | 2,9 |
Gross profit margin | 7,9 | 8 | 11,3 | 3,3 |
EBITDA Margin | 10,2 | 10 | 11,7 | 1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 102 | 82 | 78 | -4 |
Current financial liquidity indicator | 1.2218565940856934 | 1.5815571546554565 | 1.7199541330337524 | 0,1 |
Net dept to EBITDA | -0.6053218245506287 | -0.3865121006965637 | -0.16496357321739197 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane